Update on shunt closure in neonates and infants

References

• Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890–1900.
   PubMed Web of Science ®Google Scholar
• Bleuer B, Stocker F, Weber JW. [Congenital heart defects, incidence and course up to the 8th year of life]. Schweiz Med Wochenschr. 1985;115:407–411.
   PubMedGoogle Scholar
• Ferencz C, Rubin ID, McCarter R, et al. Congenital heart disease prevalence at live birth; the Baltimore-Washington Infant Study. Am Epidemiol. 1984;121:31–36.
   Web of Science ®Google Scholar
• Gillum RF. Epidemiology of congenital heart disease in the United States. Am Heart J. 1994;127:919–927.
   PubMed Web of Science ®Google Scholar
• Dickinson DF, Arnold R, Wilkinson JL. Congenital heart disease among 160480 live-born children in Liverpool 1960 to 1969. Implications for surgical treatment. Br Heart J. 1981;46:55–62.
   PubMedGoogle Scholar
• Phillips SJ, Okies JE, Henken D, et al. Complex of secundum atrial septal defect and congestive heart failure in infants.J. Thorac Cardiovasc Surg. 1975;70:696–700.
   Google Scholar
• Hunt CE, Lucas RV Jr. Symptomatic atrial septal defect in infancy. Circulation. 1973;47:1042–1048.
   PubMed Web of Science ®Google Scholar
• Dimich I, Steinfeld L, Park SC. Symptomatic atrial septal defect in infants. Am Heart J. 1973;85:601–604.
   PubMed Web of Science ®Google Scholar
• Vyas-Read S, Guglani L, Shankar P, et al. Atrial septal defects accelerate pulmonary hypertension diagnoses in premature infants. Front Pediatr. 2018;6:342.
   PubMed Web of Science ®Google Scholar
• Black MD, Freedom RM. Minimally invasive repair of atrial septal defects. Ann Thorac Surg. 1998;65:765–767.
   PubMedGoogle Scholar
• Wood AM, Holzer RJ, Texter KM, et al. Transcatheter elimination of left-to-right shunts in infants with bronchopulmonary dysplasia is feasible and safe. Congenit Heart Dis. 2011;6:330–337.
   PubMed Web of Science ®Google Scholar
• Lim DS, Matherne GP. Percutaneous device closure of atrial septal defect in a premature infant with rapid improvement in pulmonary status. Pediatrics. 2007;119:398–400.
   PubMed Web of Science ®Google Scholar
• Du ZD, Hijazi ZM, Kleinman CS, et al. for the amplatzer investigators. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol. 2002;39:1836–1844.
   PubMed Web of Science ®Google Scholar
• Helgason H, Jonsdottir G. Spontaneous closure of atrial septal defects. Pediatr Cardiol. 1999;20:195–199.
   PubMed Web of Science ®Google Scholar
• Radzik D, Davignon A, Van Doesburg N, et al. Predictive factors for spontaneous closure of atrial septal defects diagnosed in the first 3 months of life. J Am Coll Cardiol. 1993;22:851–853.
   PubMed Web of Science ®Google Scholar
• McMahon CJ, Feltes TF, Fraley JK, et al. Natural history of growth of secundum atrial septal defects and implications for transcatheter closure. Heart. 2002;87:256–259.
   PubMed Web of Science ®Google Scholar
• Masura J, Gavora P, Formanek A, et al. Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn. 1997;42:388–393.
   PubMedGoogle Scholar
• Patel A, Cao QL, Koenig PR, et al. Intracardiac echocardiography to guide closure of atrial septal defects in children less than 15 kilograms. Catheter Cardiovasc Interv. 2006;68:287–291.
   PubMed Web of Science ®Google Scholar
• Bull C, Deanfield J, De Leval M, et al. Correction of isolated secundum atrial septal defect in infancy. Arch Dis Child. 1981;56:784–786.
   PubMed Web of Science ®Google Scholar
• Spangler JG, Feldt RH, Danielson GK. Secundum atrial septal defect encountered in infancy. J Thorac Cardiovasc Surg. 1976;71:398–401.
   PubMed Web of Science ®Google Scholar
• Andrews R, Tulloh R, Magee A, et al. Atrial septal defect with failure to thrive in infancy: hidden pulmonary vascular disease? Pediatr Cardiol. 2002;23:528–530.
   PubMed Web of Science ®Google Scholar
• Mainwaring RD, Mirali-Akbar H, Lamberti JJ, et al. Secundum-type atrial septal defects with failure to thrive in the first year of life. J Card Surg. 1996;11:116–120.
   PubMed Web of Science ®Google Scholar
• Parvathy U, Balakrishnan KR, Ranjith MS, et al. Surgical closure of atrial septal defect in children under two years of age. Asian Cardiovasc Thorac Ann. 2004;12:296–299.
   PubMedGoogle Scholar
• Lammers A, Hager A, Eicken A, et al. Need for closure of secundum atrial septal defect in infancy. J Thorac Cardiovasc Surg. 2005;129:1353–1357.
   PubMed Web of Science ®Google Scholar
• Tsuda T, Davies RR, Radtke W, et al. Early surgical closure of atrial septal defect improves clinical status of symptomatic young children with underlying pulmonary abnormalities. Pediatr Cardiol. 2020;41:1115–1124.
   PubMed Web of Science ®Google Scholar
• Vogel M, Berger F, Dahnert I, et al. Treatment of atrial septal defects in symptomatic children aged less than 2 years of age using the amplatzer septal occluder. Cardiol Young. 2000;10:534–537.
   PubMed Web of Science ®Google Scholar
• Butera G, De Rosa G, Chessa M, et al. Transcatheter closure of atrial septal defect in young children: results and follow-up. J Am Coll Cardiol. 2003;42:241–245.
   PubMed Web of Science ®Google Scholar
• Diab KA, Cao QL, Bacha EA, et al. Device closure of atrial septal defects with the amplatzer septal occluder: safety and outcome in infants. J Thorac Cardiovasc Surg. 2007;134:960–966.
   PubMed Web of Science ®Google Scholar
• Abu-Tair T, Wiethoff CM, Kehr J, et al. Transcatheter closure of atrial septal defects using the GORE(®) septal occluder in children less than 10 kg of body weight. Pediatr Cardiol. 2016;37:778–783.
   PubMed Web of Science ®Google Scholar
• Haas NA, Soetemann DB, Ates I, et al. Closure of secundum atrial septal defects by using the occlutech occluder devices in more than 1300 patients: the IRFACODE project: a retrospective case series. Catheter Cardiovasc Interv. 2016;88:571–581.
   PubMed Web of Science ®Google Scholar
• Wyss Y, Quandt D, Weber R, et al. Interventional closure of secundum type atrial septal defects in infants less than 10 kilograms: indications and procedural outcome. J Interv Cardiol. 2016;29:646–653.
   PubMed Web of Science ®Google Scholar
• Chen Q, Cao H, Zhang GC, et al. Short-term and midterm follow-up of transthoracic device closure of atrial septal defect in infants. Ann Thorac Surg. 2017;104:1403–1409.
   PubMed Web of Science ®Google Scholar
• Cao C, Li R, Huang J, et al. Feasibility of Transcatheter closure of secundum atrial septal defect in low weight infants under 2-year-old from a 3-year retrospective cohort study. Am J Cardiol. 2020;132:133–139.
   PubMed Web of Science ®Google Scholar
• Białkowski J. Percutaneous closure of atrial septal defect type II - a few remarks on the basis of my own experience. Kardiol Pol. 2017;75(10):1062–1063.
   PubMed Web of Science ®Google Scholar
• Cardenas L, Panzer J, Boshoff D, et al. Transcatheter closure of secundum atrial defect in small children. Catheter Cardiovasc Interv. 2007;69:447–452.
   PubMed Web of Science ®Google Scholar
• Knop M, Szkutnik M, Fiszer R, et al. Transcatheter closure of atrial septal defect in children up to 10 kg of body weight with amplatzer device. Cardiol J. 2014;21:279–283.
   PubMed Web of Science ®Google Scholar
• Knop MT, Białkowski J, Szkutnik M, et al. Transcatheter closure of atrial septal defects type 2 in children under three years of age. Kardiol Pol. 2018;76:1257–1262.
   PubMed Web of Science ®Google Scholar
• Dalvi B, Pinto R, Gupta A. Device closure of large atrial septal defects requiring devices > or =20 mm in small children weighing <20 kg. Catheter Cardiovasc Interv. 2008;71:679–686.
   PubMed Web of Science ®Google Scholar
• Bartakian S, El-Said HG, Printz B, et al. Prospective randomized trial of transthoracic echocardiography versus transesophageal echocardiography for assessment and guidance of transcatheter closure of atrial septal defects in children using the amplatzer septal occluder. JACC Cardiovasc Interv. 2013;6:974–980.
   PubMed Web of Science ®Google Scholar
• Rudolph AM. Ventricular septal defects. In: Rudolph AM, editor. Congenital diseases of the heart: clinical-physiological considerations. 2nd ed. Armonk, NY: Publishing Company; 2001. p. 197–244.
   Google Scholar
• Anderson RH, Becker AE, Tynan M. Description of ventricular septal defects–or how long is a piece of string? Int J Cardiol. 1986;13:267–278.
   PubMed Web of Science ®Google Scholar
• Penny DJ, Vick GW III. Ventricular septal defect. Lancet. 2011;377(9771):1103–1112.
   PubMed Web of Science ®Google Scholar
• Gersony WM, Hayes CJ, Driscoll DJ, et al. Second natural history study of congenital heart defects. Quality of life of patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation. 1993;87(2 Suppl):I52–65.
   PubMed Web of Science ®Google Scholar
• Bacha EA, Cao QL, Galantowicz ME, et al. Multicenter experience with perventricular device closure of muscular ventricular septal defects. Pediatr Cardiol. 2005;26:169–175.
   PubMed Web of Science ®Google Scholar
• Hijazi ZM, Hakim F, Al-Fadley F, et al. Transcatheter closure of single muscular ventricular septal defects using the amplatzer muscular VSD occluder: initial results and technical considerations. Catheter Cardiovasc Interv. 2000;49:167–172.
   PubMed Web of Science ®Google Scholar
• Thanopoulos BD, Tsaousis GS, Konstadopoulou GN, et al. Transcatheter closure of muscular ventricular septal defects with the amplatzer ventricular septal defect occluder: initial clinical applications in children. J Am Coll Cardiol. 1999;33:1395–1399.
   PubMed Web of Science ®Google Scholar
• Hijazi ZM. Device closure of ventricular septal defects. Catheter Cardiovasc Interv. 2003;60:107–114.
   PubMed Web of Science ®Google Scholar
• Hijazi ZM, Hakim F, Haweleh AA, et al. Catheter closure of perimembranous ventricular septal defects using the new amplatzer membranous VSD occluder: initial clinical experience. Catheter Cardiovasc Interv. 2002;56:508–515.
   PubMed Web of Science ®Google Scholar
• Bacha EA, Cao QL, Starr JP, et al. Perventricular device closure of muscular ventricular septal defects on the beating heart: technique and results. J Thorac Cardiovasc Surg. 2003;126:1718–1723.
   PubMed Web of Science ®Google Scholar
• Wollenek G, Wyse R, Sullivan I, et al. Closure of muscular ventricular septal defects through a left ventriculotomy. Eur J Cardiothorac Surg. 1996;10:595–598.
   PubMed Web of Science ®Google Scholar
• Serraf A, Lacour-Gayet F, Bruniaux J, et al. Surgical management of isolated multiple ventricular septal defects. Logical approach in 130 cases. J Thorac Cardiovasc Surg. 1992;103:437–442, discussion 443
   PubMed Web of Science ®Google Scholar
• Kitagawa T, Durham LA 3rd, Mosca RS, et al. Techniques and results in the management of multiple ventricular septal defects. J Thorac Cardiovasc Surg. 1998;115:848–856.
   PubMed Web of Science ®Google Scholar
• Murzi B, Bonanomi GL, Giusti S, et al. Surgical closure of muscular ventricular septal defects using double umbrella devices (intraoperative VSD device closure). Eur J Cardiothorac Surg. 1997;12:450–454, discussion 454-5
   PubMed Web of Science ®Google Scholar
• Okubo M, Benson LN, Nykanen D, et al. Outcomes of intraoperative device closure of muscular ventricular septal defects. Ann Thorac Surg. 2001;72:416–423.
   PubMed Web of Science ®Google Scholar
• Carminati M, Butera G, Chessa M, et al. Transcatheter closure of congenital ventricular septal defect with amplatzer septal occluders. Am J Cardiol. 2005;96(12A):52L–58L.
   PubMed Web of Science ®Google Scholar
• Janorkar S, Goh T, Wilkinson J. Transcatheter closure of ventricular septal defects using the rashkind device: initial experience. Cathet Cardiovasc Diagn. 1999;46:43–48.
   Google Scholar
• Lock JE, Block PC, McKay RG, et al. Transcatheter closure of ventricular septal defects. Circulation. 1988;78:361–368.
   PubMed Web of Science ®Google Scholar
• Bridges ND, Perry SB, Keane JF, et al. Preoperative transcatheter closure of congenital muscular ventricular septal defects. N Engl J Med. 1991;324:1312–1317.
   PubMed Web of Science ®Google Scholar
• Rigby ML, Redington N. Primary transcatheter closure of perimembranous ventricular septal defect. Br Heart J. 1994;72:368–371.
   PubMedGoogle Scholar
• Sideris EB, Walsh KP, Haddad JL, et al. Occlusion of congenital ventricular septal defects by the buttoned device. Heart. 1997;77:276–279.
   PubMed Web of Science ®Google Scholar
• Kalra GS, Verma PK, Dhall A, et al. Transcatheter device closure of perimembranous septal defects: immediate results and intermediate-term follow-up. Am Heart J. 1999;138:339–344.
   PubMed Web of Science ®Google Scholar
• Diab KA, Hijazi ZM, Cao QL, et al. A truly hybrid approach to perventricular closure of multiple muscular ventricular septal defects. J Thorac Cardiovasc Surg. 2005;130:892–893.
   PubMed Web of Science ®Google Scholar
• Holzer R, Balzer D, Cao QL, et al. Amplatzer muscular ventricular septal defect investigators. Device closure of muscular ventricular septal defects using the amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry. J Am Coll Cardiol. 2004;43:1257–1263.
   PubMed Web of Science ®Google Scholar
• Chessa M, Carminati M, Cao QL, et al. Transcatheter closure of congenital and acquired muscular ventricular septal defects using the amplatzer device. J Invasive Cardiol. 2002;14:322–327.
   PubMedGoogle Scholar
• Knauth AL, Lock JE, Perry SB, et al. Transcatheter device closure of congenital and postoperative residual ventricular septal defects. Circulation. 2004;110:501–507.
   PubMed Web of Science ®Google Scholar
• Narin N, Pamukcu O, Tuncay A, et al. Percutaneous ventricular septal defect closure in patients under 1 year of age. Pediatr Cardiol. 2018;39:1009–1015.
   PubMed Web of Science ®Google Scholar
• Diab KA, Cao QL, Mora BN, et al. Device closure of muscular ventricular septal defects in infants less than one year of age using the amplatzer devices: feasibility and outcome. Catheter Cardiovasc Interv. 2007;70:90–97.
   PubMed Web of Science ®Google Scholar
• Gray RG, Menon SC, Johnson JT, et al. Acute and midterm results following perventricular device closure of muscular ventricular septal defects: a multicenter PICES investigation. Catheter Cardiovasc Interv. 2017;90:281–289.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Mukherji A, Chattopadhyay A. Percutaneous closure of moderate to large perimembranous ventricular septal defect in small children using left ventricular mid-cavity approach. Indian Heart J. 2020;72:570–575.
   PubMedGoogle Scholar
• Holzer R, De Giovanni J, Walsh KP, et al. Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: immediate and midterm results of an international registry. Catheter Cardiovasc Interv. 2006;68:620–628.
   PubMed Web of Science ®Google Scholar
• Pedra CA, Pedra SR, Esteves CA, et al. Transcatheter closure of perimembranous ventricular septal defects. Expert Rev Cardiovasc Ther. 2004;2:253–264.
   PubMedGoogle Scholar
• Fang GH, Chen Q, Hong ZN, et al. The comparison of perventricular device closure with transcatheter device closure and the surgical repair via median sternotomy for perimembranous ventricular septal defect. Ann Thorac Cardiovasc Surg. 2018;20(24):308–314.
   Google Scholar
• Chauvaud S, Serraf A, Mihaileanu S, et al. Ventricular septal defect associated with aortic valve incompetence: results of two surgical managements. Ann Thorac Surg. 1990;49(6):875–880.
   PubMed Web of Science ®Google Scholar
• Huang JS, Sun KP, Huang ST, et al. A meta-analysis of perventricular device closure of doubly committed subarterial ventricular septal defects. J Cardiothorac Surg. 2020;28(15):28.
   Google Scholar
• Tanidir IC, Baspinar O, Saygi M, et al. Use of Lifetech™ Konar-MF, a device for both perimembranous and muscular ventricular septal defects: a multicentre study. Int J Cardiol. 2020;310:43–50.
   PubMed Web of Science ®Google Scholar
• Haddad RN, Daou LS, Saliba ZS. Percutaneous closure of restrictive-type perimembranous ventricular septal defect using the new KONAR multifunctional occluder: midterm outcomes of the first middle-eastern experience. Catheter Cardiovasc Interv. 2020 Sep 1;96(3):E295- E302.
   PubMed Web of Science ®Google Scholar
• Benitz WE. Committee on fetus and newborn, American Academy of Pediatrics. Patent ductus arteriosus in preterm infants. Pediatrics. 2016;137(1):e20153730.
   Web of Science ®Google Scholar
• Gersony WM. Patent ductus arteriosus in the neonate. Pediatr Clin North Am. 1986;33:545–560.
   PubMed Web of Science ®Google Scholar
• Jim WT, Chiu NC, Chen MR, et al. Cerebral hemodynamic change and intraventricular hemorrhage in very low birth weight infants with patent ductus arteriosus. Ultrasound Med Biol. 2005;31:197–202.
   PubMed Web of Science ®Google Scholar
• Coombs RC, Morgan ME, Durbin GM, et al. Gut blood flow velocities in the newborn: effects of patent ductus arteriosus and parenteral indomethacin. Arch Dis Child. 1990;65:1067–1071.
   PubMed Web of Science ®Google Scholar
• Bancalari E. Changes in the pathogenesis and prevention of chronic lung disease of prematurity. Am J Perinatol. 2001;18:1–9.
   PubMed Web of Science ®Google Scholar
• Brooks JM, Travadi JN, Patole SK, et al. Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management. Arch Dis Child Fetal Neonatal Ed. 2005;90:235–239.
   PubMed Web of Science ®Google Scholar
• Hamrick SEG, Sallmon H, Rose AT, et al. Patent ductus arteriosus of the preterm infant. Pediatrics. 2020;146:e20201209.
   PubMed Web of Science ®Google Scholar
• Butera G, De Rosa G, Chessa M, et al. Transcatheter closure of persistent ductus arteriosus with the amplatzer duct occluder in very young symptomatic children. Heart. 2004;90:1467–1470.
   PubMed Web of Science ®Google Scholar
• Oncel MY, Erdeve O. Oral medications regarding their safety and efficacy in the management of patent ductus arteriosus. World J Clin Pediatr. 2016;5(1):75–81.
   PubMedGoogle Scholar
• Backes CH, Kennedy KF, Locke M, et al. Transcatheter occlusion of the patent ductus arteriosus in 747 infants <6 kg: insights from the NCDR IMPACT registry. JACC Cardiovasc Interv. 2017;10(17):1729–1737.
   PubMed Web of Science ®Google Scholar
• Masura J, Walsh KP, Thanopoulous B, et al. Catheter closure of moderate-large sized patent ductus arteriosus using the new Amplatzer duct occluder: immediate and short-term results. J Am Coll Cardiol. 1998;31:878–882.
   PubMed Web of Science ®Google Scholar
• Krichenko A, Benson LN, Burrows P, et al. Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol. 1989;63:877–880.
   PubMed Web of Science ®Google Scholar
• Philip R, Waller BR 3rd, Agrawal V, et al. Morphologic characterization of the patent ductus arteriosus in the premature infant and the choice of transcatheter occlusion device. Catheter Cardiovasc Interv. 2016 Feb 1;87(2):310–317.
   PubMed Web of Science ®Google Scholar
• Kenny D, Morgan GJ, Bentham, et al. Early clinical experience with a modified amplatzer ductal occluder for transcatheter arterial duct occlusion in infants and small children. Cathet Cardiovasc Interv. 2013;82:534–540.
   PubMed Web of Science ®Google Scholar
• Bentham J, Meur S, Hudsmith L, et al. Echocardiographically guided catheter closure of arterial ducts in small preterm infants on the neonatal intensive care unit. Catheter Cardiovasc Interv. 2011;77(3):409–415.
   PubMed Web of Science ®Google Scholar
• Porstmann W, Wierny L, Warnke H. Catheter closure of patent ductus arteriosus: 62 cases treated without thoracotomy. Radiol Clin North Am. 1971;9:203–218.
   PubMed Web of Science ®Google Scholar
• Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation. 2006;114:1873–1882.
   PubMed Web of Science ®Google Scholar
• Abadir S, Boudjemline Y, Rey C, et al. Significant persistent ductus arteriosus in infants less or equal to 6 kg: percutaneous closure or surgery? Arch Cardiovasc Dis. 2009;102:533–540.
   PubMed Web of Science ®Google Scholar
• Bass JL, Wilson N. Transcatheter occlusion of the patent ductus arteriosus in infants: experimental testing of a new amplatzer device. Catheter Cardiovasc Interv. 2014;83(2):250–255.
   PubMed Web of Science ®Google Scholar
• El‐Said HG, Bratincsak A, Foerster SR, et al. Safety of percutaneous patent ductus arteriosus closure: an unselected multicenter population experience. J Am Heart Assoc. 2013;2(6):e000424.
   PubMed Web of Science ®Google Scholar
• Philip R, Rush Waller B III, Agrawal V, et al. Morphologic characterization of the patent ductus arteriosus in the premature infant and the choice of transcatheter occlusion device. Catheter Cardiovasc Interv. 2016;87:310–317.
   PubMed Web of Science ®Google Scholar
• Promphan W, Qureshi SA. What interventional cardiologists are still leaving to the surgeons? Front Pediatr. 2016;4:59.
   PubMed Web of Science ®Google Scholar
• Baspinar O, Sahin DA, Sulu A, et al. Transcatheter closure of patent ductus arteriosus in under 6 kg and premature infants. J Interv Cardiol. 2015;28:180–189.
   PubMed Web of Science ®Google Scholar
• Francis E, Singhi AK, Lakshmivenkateshaiah S, et al. Transcatheter occlusion of patent ductus arteriosus in pre-term infants. JACC Cardiovasc Interv. 2010;3(5):550–555.
   PubMed Web of Science ®Google Scholar
• Gałeczka M, Szkutnik M, Białkowski J, et al. Transcatheter patent ductus arteriosus closure: what have we learned after over 25 years? A single–center experience with 1036 patients. Kardiol Pol. 2021;79:287–293.
   PubMed Web of Science ®Google Scholar
• Mahmoud HT, Santoro G, Gaio G, et al. Single‑center experience in percutaneous closure of arterial duct with amplatzer duct occluder II additional sizes. Catheter Cardiovasc Interv. 2017;89:1045–1050.
   PubMed Web of Science ®Google Scholar
• Sungur M, Karakurt C, Ozbarlas N, et al. Closure of patent ductus arteriosus in children, small infants, and premature babies with amplatzer duct occluder II additional sizes: multicenter study. Catheter Cardiovasc Interv. 2013;82:245–252.
   PubMed Web of Science ®Google Scholar
• Sathanandam SK, Gutfinger D, O’Brien L, et al. Amplatzer piccolo occluder clinical trial for percutaneous closure of the patent ductus arteriosus in patients ≥700 grams. Catheter Cardiovasc Interv. 2020;96:1266–1276.
   PubMed Web of Science ®Google Scholar
• Perez KM, Laughon MM. What is new for patent ductus arteriosus management in premature infants in 2015? Curr Opin Pediatr. 2015;27(2):158–164.
   PubMed Web of Science ®Google Scholar
• Malekzadeh-Milani S, Akhavi A, Douchin S, et al. Percutaneous closure of patent ductus arteriosus in premature infants: a French national survey. Catheter Cardiovasc Interv. 2020;95:71–77.
   PubMed Web of Science ®Google Scholar
• Markush D, Tsing JC, Gupta S, et al. Fate of the left pulmonary artery and thoracic aorta after transcatheter patent ductus arteriosus closure in low birth weight premature infants. Pediatr Cardiol. 2021;42(3):628:71–636.
   Web of Science ®Google Scholar
• Yamanaka O, Hobbs RE. Coronary artery anomalies in 126,595 patients undergoing coronary arteriography. Cathet Cardiovasc Diagn. 1990;21:28–40.
   PubMedGoogle Scholar
• Baltaxe HA, Wixson D. The incidence of congenital anomalies of the coronary arteries in the adult population. Radiology. 1977;122:47–52.
   PubMed Web of Science ®Google Scholar
• Davis JT, Allen HD, Wheller JJ, et al. Coronary artery fistula in the pediatric age group: a 19-year institutional experience. Ann Thorac Surg. 1994;58:760–763.
   PubMed Web of Science ®Google Scholar
• Karazisi C, Eriksson P, Dellborg M. Coronary artery fistulas: case series and literature review. Cardiology. 2017;136:93–101.
   PubMed Web of Science ®Google Scholar
• Sherwood MC, Rockenmacher S, Colan SD, et al. Prognostic significance of clinically silent coronary artery fistulas. Am J Cardiol. 1999;83:407–411.
   PubMed Web of Science ®Google Scholar
• Qureshi SA. Coronary arterial fistulas. Orphanet J Rare Dis. 2006;1:51.
   PubMed Web of Science ®Google Scholar
• Levin DC, Fellows KE, Abrams HL. Hemodynamically significant primary anomalies of the coronary arteries. Circulation. 1978;58:25–34.
   PubMed Web of Science ®Google Scholar
• Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease). Circulation. 2008;118:2395–2451.
   PubMed Web of Science ®Google Scholar
• Sharland GK, Konta L, Qureshi SA. Prenatal diagnosis of isolated coronary artery fistulas: progression and outcome in five cases. Cardiol Young. 2016;26:915–920.
   PubMed Web of Science ®Google Scholar
• Armsby LR, Keane JF, Sherwood MC, et al. Management of coronary artery fistulae. Patient selection and results of transcatheter closure. J Am Coll Cardiol. 2002;39:1026–1032.
   PubMed Web of Science ®Google Scholar
• Mottin B, Baruteau A, Boudjemline Y, et al. Transcatheter closure of coronary artery fistulas in infants and children: a French multicenter study. Catheter Cardiovasc Interv. 2016;15(87):411–418.
   Google Scholar
• Al-Qahtani A, Zakaria A, Hijazi ZM. Current interventional management strategies for coronary arteriovenous fistulae. J Struct Heart Dis. 2018;4(5):212–221.
   Google Scholar
• Zhang W, Hu R, Zhang L, et al. Outcomes of surgical repair of pediatric coronary artery fistulas. J Thorac Cardiovasc Surg. 2016;152:1123–1130.e1.
   Google Scholar
• Li X, Song L, Xu M, et al. Long-term follow-up of pediatric patients after congenital coronary artery fistula closure. Pediatr Cardiol. 2020;41:1346–1353.
   PubMed Web of Science ®Google Scholar
• Hong GJ, Lin CY, Lee CY, et al. Congenital coronary artery fistulas: clinical considerations and surgical treatment. Ann J Surg. 2003;74:350–355.
   Google Scholar
• Eicken A, Sebening W, Genz T, et al. Coil embolization of congenital coronary arterial fistulas. Pediatric Cardiol. 2003;24:149–153.
   PubMed Web of Science ®Google Scholar
• Okubo M, Nykanen D, Benson LN. Outcomes of transcatheter embolization in the treatment of coronary artery fistulas. Cathet Cardiovasc Interv. 2001;52:510–517.
   PubMed Web of Science ®Google Scholar
• Qureshi SA, Tynan M. Catheter closure of coronary artery fistulas. J Interv Cardiol. 2001;14:299–307.
   PubMedGoogle Scholar
• Holzer R, Waller BR, Kahana M, et al. Percutaneous closure of a giant coronary arteriovenous fistula using multiple devices in a 12-day-old neonate. Catheter Cardiovasc Interv. 2003;60:291–294.
   PubMed Web of Science ®Google Scholar
• Van Praagh S, Geva T, Lock JE, et al. Biatrial or left atrial drainage of the right superior vena cava: anatomic, morphogenetic, and surgical considerations—report of three new cases and literature review. Pediatr Cardiol. 2003;24(4):350–363.
   PubMed Web of Science ®Google Scholar
• Aliter H, El-Haddad A, Gallo R, et al. Atrial septal defect with drainage of the inferior vena cava into the left atrium. Eur J Cardiothorac Surg. 2011;40(5):1256–1257.
   PubMed Web of Science ®Google Scholar
• Beitzke D, Koestenberger M, Knez I, et al. Anomalous connection of the inferior vena cava to the left atrium: a surgical error in closing an atrial septal defect. Clin Res Cardiol. 2008;97(3):191–193.
   PubMed Web of Science ®Google Scholar
• Looyenga DS, Lacina SJ, Gebuhr CJ, et al. Persistent left superior vena cava communicating with the left atrium through a systemic-pulmonary venous malformation. J Am Coll Cardiol. 1986;8(3):621–626.
   PubMed Web of Science ®Google Scholar
• Lucas RV Jr, Lund GW, Edwards JE. Direct communication of a pulmonary artery with the left atrium: an unusual variant of pulmonary arteriovenous fistula. Circulation. 1961;24:1409–1414.
   PubMed Web of Science ®Google Scholar
• Kroeker EJ, Adams HD, Leon AS, et al. Congenital communication between a pulmonary artery and the left atrium: physiologic observations and review of the literature. Am J Med. 1963;34:721–725.
   PubMed Web of Science ®Google Scholar
• Bauersfeld SR, Zuberbuhler JR, Ford WB. Right pulmonary artery left atrial communication. Am Heart J. 1964;67:244–250.
   PubMed Web of Science ®Google Scholar
• Ohara H, Ito K, Kohguchi N, et al. Direct communication between the right pulmonary artery and the left atrium: a case report and review of the literature. J Thorac Cardiovasc Surg 1979;77:742–747.
   Google Scholar
• Orlick AE, Hultgren N, Stoner JD, et al. Traumatic pulmonary artery-left atrial fistula: an unusual case of cyanosis in an adult. Am Heart J. 1979;98:366–370.
   PubMed Web of Science ®Google Scholar
• Karnik AM, Nilsson U, Vijayaraghavan G, et al. Direct communication between the left pulmonary artery and the left atrium. Chest. 1989;96:937–939.
   PubMed Web of Science ®Google Scholar
• Nelson ASS, Giulani ER, Davis GD, et al. Communication between the right pulmonary artery and left atrium. Am J Cardiol. 1974;34:857–863.
   PubMedGoogle Scholar
• Nonoyama A, Itano T, Takimoto R, et al. An unusual variant of pulmonary arteriovenous fistula. J Jpn Assoc Thorac Surg. 1966;14:404–407.
   Google Scholar
• Zeebregts CJAM, Nijveld A, Lam J, et al. Surgical treatment of a fistula between the right pulmonary artery and the left atrium: presentation of two cases and review of the literature. Eur J Cardiol Thorac Surg. 1997;11:1056–1061.
   PubMed Web of Science ®Google Scholar
• Mobley MM, Stroup RE, Kaine SF. Comparative risk of cardiac catheterisations performed on low birth weight neonates. Cardiol Young. 2013;23:722–726.
   PubMed Web of Science ®Google Scholar